依达拉奉治疗急性脑栓塞的临床效果与不良反应分析  

Analysis of the Clinical Effect and Adverse Reaction of Edaravone in Treatment of Acute Cerebral Embolism

作　　者：张桂茹[1] Zhang Gui-ru(Department of Neurology,Provincial Hospital Affiliated to Shandong University,Jinan 250022, China)

机构地区：[1]山东大学附属省立医院神经内科,济南250022

出　　处：《中国医药导刊》2016年第9期911-912,共2页Chinese Journal of Medicinal Guide

摘　　要：目的：探讨论依达拉奉应用在急性脑栓塞患者治疗中的临床效果。方法：将2014年11月～2015年11月期间我院收治的96例急性脑栓塞患者分为两组：对照组和试验组，每组48例。对照组采用血栓通治疗，试验组采用依达拉奉治疗。结果：对照组的临床总有有效率为75.00%，试验组患者的临床总有效率为95.83%，试验组患者的临床疗效明显的比对照组高（P＜0.05）；在用药期间全部患者都没有出现肝肾功能损伤等不良反应。结论：依达拉奉应用在急性脑栓塞患者治疗中疗效确切，可明显改善患者临床症状，对于减少并发症发生率以及提升患者生存质量等方面具有重要作用。Objective: To explore the clinical effect of edaravone in the treatment of patients with acute cerebral embolism.Methods:96 cases of patients with acute cerebral embolism were divided into two groups:control group and experimental group,48cases in each group,the control group and the experimental group,the patients in our hospital during Nov 2014 ~ Nov 2015.Thecontrol group using Xueshuantong treatment,experimental group was treated with edaravone.Results:In the control group,theclinical total efficiency was 75.00%,and patients in the experimental group the total clinical effective rate was 95.83%,test groupof patients with clinical curative effect than that of the control group (P<0.05); during the treatment all patients did not appearliver and kidney function damage and other adverse reactions.Conclusion:Application of edaravone in the treatment of patientswith acute cerebral embolism curative effect is exact,and can obviously improve the clinical symptoms of patients and to decreasethe complication rate and improve the life quality of the patients and has a crucial role.

关 键 词：依达拉奉 急性脑栓塞 临床效果 不良反应 

分 类 号：R743.33[医药卫生—神经病学与精神病学]